Health Catalyst Deferred Revenue 2011-2026 | HCAT

Deferred revenue is the amount of money or obligations that a company has received in advance for goods or services that have not yet been delivered or performed. In other words, it is income that has already been received but has not yet been recognized in accounting as revenue because the goods or services have not yet been transferred to the customer.

Features of the metric

Sources of future cash inflows
A high level of deferred revenue indicates that the company has secured future cash flows, which positively affects forecasts of its financial condition and stability.
Assessment of operational stability
Deferred revenue reflects demand for the company’s products or services and its ability to attract customers willing to pay in advance. It is one of the indicators of business stability and its competitive advantages.
Risks and obligations
Although deferred revenue indicates future inflows, it also represents obligations that the company must fulfill. If fulfilling these obligations is delayed or impossible, it can negatively impact reputation and financial results.
Analysis of liquidity and cash flow
Inflows in the form of deferred revenue improve the company’s current liquidity since the funds are already in the accounts. However, investors need to assess the ratio of deferred revenue to fulfilled obligations to understand the actual financial capabilities and risks.
Impact on company valuation
In fundamental analysis, deferred revenue is taken into account for accurate revenue and profit forecasting, especially in industries with long-term contracts or subscriptions (e.g., IT sector, services, manufacturing).

Annual Deferred Revenue Health Catalyst

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
56.1 M	53.3 M	55.8 M	55 M	56.6 M	47.1 M	30.7 M	24.8 M	10.7 M	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
56.6 M	10.7 M	43.3 M

Quarterly Deferred Revenue Health Catalyst

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
58.8 M	67 M	71.5 M	53.3 M	-	-	-	53.1 M	55 M	-	-	61.8 M	56.6 M	55.3 M	55.6 M	51.6 M	47.1 M	47.1 M	47.1 M	47.1 M	30.7 M	30.7 M	30.7 M	30.7 M	24.8 M	24.8 M	24.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
71.5 M	24.8 M	46.6 M

Deferred Revenue of other stocks in the Health information services industry

Issuer	Deferred Revenue	Price	% 24h	Market Cap	Country
Accolade ACCD	25.9 M	-	0.29 %	$ 206 M	USA
Change Healthcare CHNG	469 M	-	-	$ 9.03 B	USA
Cerner Corporation CERN	531 M	-	-	$ 27.9 B	USA
American Well Corporation AMWL	22.6 M	$ 5.63	-2.26 %	$ 90.3 M	USA
HealthStream HSTM	84.2 M	$ 21.23	1.24 %	$ 645 M	USA
Computer Programs and Systems CPSI	8.68 M	-	4.4 %	$ 133 M	USA
Covetrus CVET	28 M	-	-	$ 2.94 B	USA
iCAD ICAD	3.86 M	-	-	$ 102 M	USA
Castlight Health, Inc. CSLT	6.85 M	-	-7.28 %	$ 227 M	USA
Inovalon Holdings, Inc. INOV	10.9 M	-	-	$ 6.37 B	USA
NextGen Healthcare NXGN	52.9 M	-	-	$ 1.6 B	USA
1Life Healthcare ONEM	47.9 M	-	-	$ 3.37 B	USA
Premier PINC	22.5 M	-	-	$ 2.33 B	USA
Omnicell OMCL	141 M	$ 34.94	1.39 %	$ 1.61 B	USA
Phreesia PHR	24.1 M	$ 11.28	-	$ 615 M	USA
OptimizeRx Corporation OPRX	172 K	$ 7.18	5.9 %	$ 123 M	USA
Evolent Health EVH	5.76 M	$ 2.27	0.89 %	$ 213 M	USA
Schrödinger SDGR	113 M	$ 11.4	-1.47 %	$ 837 M	USA
MTBC MTBC	4.15 M	-	-0.58 %	$ 51.7 M	USA
Teladoc Health TDOC	62.3 M	$ 5.57	2.77 %	$ 982 M	USA
GoodRx Holdings GDRX	6.04 M	$ 2.06	0.98 %	$ 795 M	USA
Signify Health SGFY	2.4 M	-	-0.02 %	$ 7.21 B	USA
SCWorx Corp. WORX	354 K	$ 0.13	1.5 %	$ 190 K	USA
R1 RCM RCM	83.9 M	-	-	$ 3.81 B	USA
Akerna Corp. KERN	569 K	-	-	$ 161 M	USA
Zhongchao ZCMD	6.76 K	$ 1.8	-0.55 %	$ 9.37 M	China
Allscripts Healthcare Solutions MDRX	326 M	-	-10.39 %	$ 886 M	USA
NantHealth NH	2.72 M	-	-46.64 %	$ 10.4 M	USA
10x Genomics TXG	13.2 M	$ 20.91	5.55 %	$ 2.45 B	USA
Streamline Health Solutions STRM	6.1 M	-	-	$ 21.4 M	USA
Tabula Rasa HealthCare TRHC	4.86 M	-	-	$ 255 M	USA
So-Young International SY	135 M	$ 3.19	9.62 %	$ 253 M	China
Veeva Systems VEEV	1.49 B	$ 178.11	-0.56 %	$ 29.2 B	USA